• Booth: 3054

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Elafibranor, its lead drug, reverses NASH to prevent progression to cirrhosis.

Do you have questions about getting the most from your eBooth? Check the eBooth FAQ.